Search

Your search keyword '"Florin Andrei"' showing total 1,038 results

Search Constraints

Start Over You searched for: Author "Florin Andrei" Remove constraint Author: "Florin Andrei"
1,038 results on '"Florin Andrei"'

Search Results

1. Evaluation of the Immunohistochemical Scoring System of CDX2 Expression as a Prognostic Biomarker in Colon Cancer

2. Impact of Structural Strain in Perovskite Epitaxial Thin Films on Their Functional Properties

3. SAF-T – The Reporting that Will Improve the Collection?

4. Clinicopathological correlations of neuroendocrine cell hyperplasia in ulcerative colitis patients

5. Histological scoring systems in ulcerative colitis patients: a routine practice perspective

6. Multispectral Data Analysis for Semantic Assessment—A SNAP Framework for Sentinel-2 Use Case Scenarios

7. Nitrites Detection with Sensors Processed via Matrix-Assisted Pulsed Laser Evaporation

8. Kaolinite Thin Films Grown by Pulsed Laser Deposition and Matrix Assisted Pulsed Laser Evaporation

9. Platelet Activation and Inflammation in Patients with Papillary Thyroid Cancer

11. Thickness-Dependent Photoelectrochemical Water Splitting Properties of Self-Assembled Nanostructured LaFeO3 Perovskite Thin Films

13. The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype

14. Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

15. The Influence of the Structural and Morphological Properties of WO3 Thin Films Obtained by PLD on the Photoelectrochemical Water-Splitting Reaction Efficiency

20. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.

21. Return of individual genomic research results within the PRAEGNANT multicenter registry study

22. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics – A retrospective analysis of a real world registry

23. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.

24. L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile

25. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.

26. Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

27. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis

28. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

29. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

30. Vulvar Malignancies

31. Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability – Real-World Data from German Breast Centers.

32. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

33. Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study

35. Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer

36. Evaluation of the Immunohistochemical Scoring System of CDX2 Expression as a Prognostic Biomarker in Colon Cancer

37. CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – an Overview of Current Programs

38. Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry

39. Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020

41. Klinische Endpunkte in Real-World-Register-Studien: PRAEGNANT-Netzwerk für Patientinnen mit fortgeschrittenem Mammakarzinom

44. Screening and evaluation of potential recipients and donors for living donor uterus transplantation: results from a single-center observational study

46. Update Mammakarzinom 2023 Teil 2 – Brustkrebs in fortgeschrittenen Krankheitsstadien

47. Update Mammakarzinom 2023 Teil 3 – Expertenmeinungen zu Brustkrebs in frühen Krankheitsstadien

48. TERT promoter mutation in adult granulosa cell tumor of the ovary

49. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

50. Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry

Catalog

Books, media, physical & digital resources